Public Health Impact Assessment - Guanidinoacetate methyltransferase (GAMT) Deficiency
The webinar features presentations on newborn screening for GAMT, a brief update from the two newborn screening programs currently screening for GAMT in the United States, and an overview of upcoming public health system impact (PHI) assessment survey for GAMT.
- Dr. Alex Kemper, MD, MPS, MS, Division Chief of Primary Care Pediatrics, Nationwide Children's Hospital
- Mar Morrissey, PhD, Research Scientist, Newborn Screening, Wadsworth Center, New York State Department of Health
- Kim Hart, MS, LCGC, Program Manager, Newborn Screening Program, Utah Department of Health
- Jelili Ojodu, MPH, Director, Newborn Screening and Genetics, Association of Public Health Laboratories